Evidence map›Paper›PMID 27554343›Full record

ArticleEpilepsia2016

The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutations.

J Lloyd Holder, Michael M Quach

Open access · greenAbstract read
In one paragraph

Article in Epilepsia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Heterogeneity of monogenic epilepsy in loci, phenotypes, and treatment approaches.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Developmental and epileptic encephalopathies.Nature reviews. Disease primers · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Haploinsufficiency ofThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  17. Article
  18. Updated consensus guidelines on the management of Phelan-McDermid syndrome.American journal of medical genetics. Part A · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

J Lloyd HolderBaylor College of Medicine and Texas Children's Hospital, Houston, Texas, U.S.A.. holder@bcm.edu.
Michael M QuachBaylor College of Medicine and Texas Children's Hospital, Houston, Texas, U.S.A.
Baylor College of Medicine · USTexas Children's Hospital · US

Funding

RESCUING MOTOR DEFICITS IN SHANK3 RELEATED DISORDERSK08NS091381 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI HOLDER, JIMMY L · 2015 to 2019
$908k
NINDS NIH HHS K08 NS091381
6 · The paper itself

Abstract

objectiveThe coincidence of autism with epilepsy is 27% in those individuals with intellectual disability.

methodsA retrospective chart review was performed of all individuals treated at the Blue Bird Circle Clinic for Child Neurology who have been identified as having either a chromosome 22q13 microdeletion encompassing SHANK3 or a loss-of-function mutation in SHANK3 identified through whole-exome sequencing. For each subject, the presence or absence of seizures, seizure semiology, frequency, age of onset, and efficacy of therapy were determined. Electroencephalography studies were reviewed by a board certified neurophysiologist. Neuroimaging was reviewed by both a board certified pediatric neuroradiologist and child neurologist.

resultsThere is a wide spectrum of seizure semiologies, frequencies, and severity in individuals with SHANK3 mutations. There are no specific EEG abnormalities found in our cohort, and EEG abnormalities were present in individuals diagnosed with epilepsy and those without history of a clinical seizure. SIGNIFICANCE: All individuals with a mutation in SHANK3 should be evaluated for epilepsy due to the high prevalence of seizures in this population. The most common semiology is atypical absence seizure, which can be challenging to identify due to comorbid intellectual disability in individuals with SHANK3 mutations; however, no consistent seizure semiology, neuroimaging findings, or EEG findings were present in the majority of individuals with SHANK3 mutations.

Indexed as

AdolescentAnticonvulsantsBrain WavesChildChild, PreschoolChromosome AberrationsChromosome DeletionChromosome DisordersChromosomes, Human, Pair 22ElectroencephalographyEpilepsyFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleAnticonvulsantsNerve Tissue ProteinsSHANK3 protein, humanAutismElectroencephalographyEpilepsyPhelan-McDermid syndromeSHANK3

Identifiers

PMID27554343
PMCPMC5547884
OpenAlexW2517538004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.